Amid global market volatility, TipRanks offers valuable tools to guide investors. One of the most powerful is the Smart Score, which assigns a ranking of one to ten to stocks and highlights their potential to outperform the broader market. Using this tool, we have identified three standout stocks: Abbott Laboratories (ABT), Levi Strauss & Co. (LEVI), and BlueLinx Holdings (BXC). Each of these has earned a top Smart Score and a Strong Buy rating from Wall Street analysts.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The TipRanks Smart Score rates the stocks on a scale from 1 to 10, with 10 being the highest. The score is based on eight key market factors, including Wall Street analyst ratings, insider transactions, financial blogger opinions, and more. Additionally, the Top Smart Score Stocks list offers a comprehensive selection of stocks rated a perfect 10, along with advanced filtering options.
Let’s dive into the details.
Is Abbott a Good Stock to Buy?
Based in the U.S., Abbott is a healthcare company that develops medical devices, diagnostics, nutrition products, and branded generic medicines, with a strong focus on areas like diabetes care and cardiovascular health.
Year-to-date, ABT stock has gained nearly 17%. Looking ahead, Wall Street analysts remain bullish on its upside potential. Of the 21 analysts covering the stock, 17 rate it a Buy, while four have a Hold rating. The average Abbott stock price target of $144.60 suggests a potential upside of almost 10% from current levels.
Is LEVI a Good Stock to Buy Now?
Levi Strauss & Co. is an American apparel company best known for its iconic Levi’s denim jeans. Year-to-date, LEVI stock has gained over 23%.
Wall Street analysts are optimistic about LEVI stock, with eight Buy and two Hold ratings. According to TipRanks, the stock has an average price target of $22.70, suggesting a 6.2% upside from current levels.
What Is the Price Target for BlueLinx Stock?
BlueLinx sells and delivers a wide range of building materials, including both basic and specialty products like lumber, siding, and panels.
Wall Street analysts are strongly bullish on BXC stock, with all three analysts rating it a Buy. The average BlueLinx stock price target of $93.33 points to an 11.3% upside from current levels. However, the stock is currently down nearly 18% year-to-date.
